Insmed Incorporated
INSM
$149.33
-$0.67-0.45%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 85.36% | 32.52% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 85.36% | 32.52% | |||
| Cost of Revenue | 50.59% | 4.59% | |||
| Gross Profit | 94.40% | 42.40% | |||
| SG&A Expenses | 14.01% | 20.43% | |||
| Depreciation & Amortization | 25.94% | 21.77% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 27.21% | 11.74% | |||
| Operating Income | 4.46% | -2.94% | |||
| Income Before Tax | 11.33% | -15.06% | |||
| Income Tax Expenses | 17.50% | 6.19% | |||
| Earnings from Continuing Operations | 11.23% | -15.03% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 11.23% | -15.03% | |||
| EBIT | 4.46% | -2.94% | |||
| EBITDA | 5.12% | -2.88% | |||
| EPS Basic | 12.01% | -2.83% | |||
| Normalized Basic EPS | 3.57% | 9.72% | |||
| EPS Diluted | 12.11% | -2.94% | |||
| Normalized Diluted EPS | 3.57% | 9.72% | |||
| Average Basic Shares Outstanding | 0.89% | 11.86% | |||
| Average Diluted Shares Outstanding | 0.89% | 11.86% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||